Guizhou Bailing (002424.SZ) announced that the company received the Guizhou Securities Regulatory Bureau's “On Pharmaceuticals for Guizhou Bailing Enterprise Group...
Zhitong Finance App News, Guizhou Bailing (002424.SZ) announced that the company received the Guizhou Securities Regulatory Bureau's “Decision on Ordering Corrective Measures against Guizhou Bailing Enterprise Group Pharmaceutical Co., Ltd. and issuing warning letters against Jiang Wei, Niu Min, and Li Hongxing”. The decision states:
The company has problems such as sales expenses for previous years not being recorded in a timely manner, physical giveaways not being recorded in a timely manner, incorrect reporting of actual taxes and fees, irregular asset group goodwill impairment tests, internal failure to offset profit and loss, delays in revenue recognition, and inaccurate calculation of bad debt preparations. As a result of the above matters, the disclosure of the company's 2021 and 2022 annual report information was inaccurate.